Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 9/20 | 0.72 |
| ▸ | MAPK14 | Q16539 | 5/20 | 0.72 |
| ▸ | RET | P07949 | 4/20 | 0.72 |
| ▸ | SRC | P12931 | 3/20 | 0.72 |
| ▸ | ABL1 | P00519 | 3/20 | 0.72 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.72 |
| ▸ | MAP3K20 | Q9NYL2 | 3/20 | 0.72 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.72 |
| ▸ | PLK4 | O00444 | 2/20 | 0.72 |
| ▸ | AURKA | O14965 | 2/20 | 0.72 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.72 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.72 |
| ▸ | LCK | P06239 | 2/20 | 0.72 |
| ▸ | FYN | P06241 | 2/20 | 0.72 |
| ▸ | LYN | P07948 | 2/20 | 0.72 |
| ▸ | RPS6KB1 | P23443 | 2/20 | 0.72 |
| ▸ | AXL | P30530 | 2/20 | 0.72 |
| ▸ | FRK | P42685 | 2/20 | 0.72 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.72 |
| ▸ | BLK | P51451 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12500767 | 0.91 | RAF1 (0.73) | KDRMAPK14RETSRCABL1 | |
| SCHEMBL15366825 | 0.90 | KDR (0.65) | KDRMAPK14RETSRCABL1 | |
| SCHEMBL19888709 | 0.87 | KDR (0.76) | KDRMAPK14RETSRCABL1 | |
| SCHEMBL12391532 | 0.86 | RAF1 (0.76) | KDRMAPK14RETSRCABL1 | |
| SCHEMBL257980 | 0.86 | RAF1 (0.82) | KDRMAPK14RETSRCABL1 | |
| SCHEMBL5569372 | 0.85 | KDR (0.74) | KDRMAPK14RETSRCABL1 | |
| SCHEMBL12500709 | 0.85 | RAF1 (0.67) | KDRMAPK14RETSRCABL1 | |
| SCHEMBL16628069 | 0.85 | KDR (0.73) | KDRMAPK14RETSRCABL1 | |
| SCHEMBL16628085 | 0.84 | KDR (1.00) | KDRMAPK14RETSRCABL1 | |
| SCHEMBL28615366 | 0.83 | KDR (0.71) | KDRMAPK14RETSRCABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8937088-B2 | Ureas for the treatment and prevention of cancer | ASTAR BIOTECH LLC (US) | 2015-01-20 | — | — | US | claimed |
| US-20130296380-A1 | Novel Ureas for the Treatment and Prevention of Cancer | BETA PHARMA CANADA INC. (CA) | 2013-11-07 | — | — | US | claimed |
| US-8937088-B2 | Ureas for the treatment and prevention of cancer | ASTAR BIOTECH LLC (US) | 2015-01-20 | — | — | US | disclosed |
| US-20130296380-A1 | Novel Ureas for the Treatment and Prevention of Cancer | BETA PHARMA CANADA INC. (CA) | 2013-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296380-A1 | Novel Ureas for the Treatment and Prevention of Cancer | FLT1, FLT4, KIT | KDR 5/4885MAPK14 585/4885RET 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.